Sectors
GLMD
Galmed Pharmaceuticals Ltd.
0.47
1 x 0.47
1 x 0.49
bid
ask
-
0.05
8.96%
12:56 PM
timesize
| Ytd | -37.04% | |
| 1y | -73.31% |
0.46
day range
0.52
0.41
52 week range
2.09
| Open | 0.52 | Prev Close | 0.52 | Low | 0.46 | High | 0.52 | Mkt Cap | 2.84M |
| Vol | 267.07K | Avg Vol | 726.92K | EPS | -1.24 | P/E | -0.42 | Forward P/E | -2.94 |
| Beta | 0.75 | Short Ratio | 0.27 | Inst. Own | 0.48% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 09-01 | 50-d Avg | 0.59 | 200-d Avg | 0.80 | 1yr Est | 12.00 |
| Income Statement | |||
| Operating Expenses | 2.04M | ||
| Research and Development Expense | 1.36M | ||
| Selling, General and Administrative Expense | 684.00K | ||
| Operating Income | -2.04M | ||
| Interest Expense | -134.00K | ||
| Net Income | -1.91M | ||
| Net Income Common Stock | -1.91M | ||
| Net Income Common Stock (USD) | -1.91M | ||
| Consolidated Income | -1.91M | ||
| Earnings per Basic Share | -0.29 | ||
| Earnings per Basic Share (USD) | -0.29 | ||
| Earnings per Diluted Share | -0.29 | ||
| Earning Before Interest & Taxes (EBIT) | -2.04M | ||
| Earning Before Interest & Taxes (USD) | -2.04M | ||
| Weighted Average Shares | 6.59M | ||
| Weighted Average Shares Diluted | 6.59M | ||
| Balance Sheet | |||
| Cash and Equivalents | 1.73M | ||
| Cash and Equivalents (USD) | 1.73M | ||
| Investments | 13.85M | ||
| Investments Current | 13.85M | ||
| Trade and Non-Trade Receivables | 451.00K | ||
| Current Assets | 16.03M | ||
| Total Assets | 16.03M | ||
| Current Liabilities | 2.08M | ||
| Total Liabilities | 2.08M | ||
| Accumulated Retained Earnings (Deficit) | -212.69M | ||
| Accumulated Other Comprehensive Income | -383.00K | ||
| Shareholders Equity | 13.95M | ||
| Shareholders Equity (USD) | 13.95M | ||
| Trade and Non-Trade Payables | 2.08M | ||
| Cash Flow | |||
| Net Cash Flow / Change in Cash & Cash Equivalents | -2.38M | ||
| Net Cash Flow from Investing | 152.00K | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 152.00K | ||
| Net Cash Flow from Operations | -2.54M | ||
| Share Based Compensation | 156.00K | ||